simian virus 40

simian virus 40 is a Polyomavirus first identified in 1960 as a contaminant in poliovirus vaccines. It naturally infects rhesus macaques and other Old World monkeys, typically without causing symptoms. The virus gained significant scientific notoriety due to its ability to cause tumors in laboratory rodents and its subsequent, controversial investigation as a potential human carcinogen. Its DNA genome and transformative properties have made it a pivotal model system in molecular biology, virology, and cancer research.

History and discovery

The virus was discovered in 1960 by Bernice Eddy and colleagues at the National Institutes of Health while examining batches of the Salk polio vaccine. These vaccines were produced using kidney cell cultures derived from rhesus macaques, which were later found to harbor the previously unknown virus. Its identification prompted a major public health investigation led by agencies like the Food and Drug Administration. Subsequent research by Maurice Hilleman at the Merck Institute confirmed its presence and led to a switch to using African green monkey cells, which do not carry the virus, for vaccine production. The discovery sparked decades of research into its biology and potential risks, involving prominent scientists like Renato Dulbecco, David Baltimore, and Howard Temin.

Structure and genome

The virion is an icosahedral particle approximately 45 nanometers in diameter, lacking a lipid envelope. Its capsid is composed of 72 pentameric capsomeres made from the viral proteins VP1, VP2, and VP3. Inside the capsid lies a small, circular, double-stranded DNA genome of about 5.2 kilobase pairs, which is associated with cellular histones to form a minichromosome. The genome is functionally divided into an early region and a late region, transcribed in opposite directions from a common non-coding regulatory region containing the origin of replication and promoter elements for both early and late genes.

Replication and life cycle

The virus enters permissive cells, such as those from monkeys, via endocytosis and traffics to the nucleus. The early genes, large T-antigen and small t-antigen, are expressed first; large T-antigen is a multifunctional protein essential for initiating viral DNA replication and regulating viral and cellular transcription. Following genome replication, the late genes encoding the structural proteins VP1, VP2, and VP3 are expressed. New virions are assembled in the nucleus and released upon cell lysis. In non-permissive cells from species like hamsters or humans, the early proteins can drive immortalization and transformation by inactivating key tumor suppressors like p53 and pRb.

Association with human disease

The potential link between the virus and human cancer has been a subject of extensive and often contentious research since the 1960s. Epidemiological studies of populations exposed to contaminated polio vaccines have not provided conclusive evidence of increased cancer incidence. However, viral DNA and proteins have been detected in some human tumors, including mesotheliomas, brain tumors, and bone cancers, using techniques like PCR and immunohistochemistry. Major research institutions like the National Cancer Institute and the International Agency for Research on Cancer have evaluated the evidence, with the latter classifying the virus as possibly carcinogenic to humans. The debate centers on whether its presence in tumors is a causative factor or a harmless passenger.

Use in research and biotechnology

The virus has been an indispensable tool in biomedical science. Its large T-antigen is widely used to immortalize primary cell cultures, creating stable lines for research. The viral origin of replication and early promoter region form the backbone of many mammalian expression vectors, such as those used in COS cell systems. Studies of its replication and T-antigen functions provided foundational insights into eukaryotic DNA replication, transcriptional control, and the mechanisms of cell cycle regulation and oncogenesis. Its role in the discovery of RNA splicing by Phillip Sharp and Richard Roberts further underscores its historical importance in molecular biology.

Category:Polyomaviruses Category:Oncoviruses Category:Vaccine contamination